George Washington University said half of its coronavirus vaccine trial participants are of people of color, exceeding a previously set goal of 30 percent.
GW’s 500-person trial is part of Moderna’s vaccine hopeful phase 3 program, WTTG-TV (Channel 5) reported. The university’s portion of the trial will terminate when 500 participants or 30,000 people are enrolled nationwide.
The Washington Post first reported the recruitment success, which comes despite generations of wariness of the medical profession among Blacks, partly because of the coronavirus’s disproportionate effect on the Black community. A Post data analysis found that majority-Black counties had three times the rate of infections and almost six times the rate of deaths as White-majority counties.